CMS finalizes key elements of the CY 2026 Medicare Advantage and Medicare Part D final rule, including insulin coverage expansion, Prescription Payment Plan codification, pharmacy data requirements, and updated enrollee protections.
CMS drives healthcare efficiency with initiatives like the HL7 FHIR Connectathon, Oklahoma directory pilot, HIPAA updates, and new prior authorization rules for Medicare and Medicaid.
Summary of Trump's executive order directing HHS to reduce prescription drug costs, focusing on Medicare reimbursement for 340B drugs, IRA drug pricing provisions, and CMS premium stabilization efforts.
Medicare Part B now covers a wide range of telehealth services, enhancing healthcare access for millions of beneficiaries via virtual care platforms offering primary and urgent care nationwide.
Federal budget cuts targeting Medicare and Medicaid create challenges for Arizona's healthcare system, threatening rural hospitals and vulnerable populations dependent on AHCCCS coverage.
Explore how UnitedHealth Group's subsidiary Optum is navigating challenges while achieving robust growth, including its strategic acquisitions and legal battles.
A detailed overview of the ongoing legal challenge by NYC municipal retirees to retain traditional Medicare supplemental insurance against a proposed switch to Medicare Advantage.
Exploring the challenges and strategies for U.S. healthcare finance leaders in the transition to value-based care with the rise of Medicare Advantage and Medicaid Managed Care.
U.S. lawmakers are requesting a GAO investigation into Medicare Advantage organizations' business strategies, concerning adherence to federal health care spending requirements.
President Trump signed an executive order to lower Medicare drug prices by enhancing drug price negotiations, increasing market transparency, and targeting anti-competitive behaviors.
